ASC 42
Alternative Names: ASC-42Latest Information Update: 08 Apr 2024
At a glance
- Originator Ascletis
- Class Antivirals; Hepatoprotectants
- Mechanism of Action Farnesoid X-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Hepatitis B; Non-alcoholic steatohepatitis; Primary biliary cirrhosis